PREGNANCY IN CHRONIC KIDNEY DISEASE STAGE 4: A CASE SERIES FROM A REFERRAL CENTER Article Demyanova K.A., Kozlovskaya N.L., Zakharova E.V., Korotchaeva Y.V., Apresyan S.V., Vorobyeva M.A., Piccoli G.B. Нефрология и диализ. Общеросийская общественная организация нефрологов Российское диализное общество. Vol. 25. 2023. P. 284-293
ANALYSIS OF THE COURSE AND OUTCOMES OF PREGNANCY IN PATIENTS WITH ADVANCED STAGES CHRONIC KIDNEY DISEASE [АНАЛИЗ ТЕЧЕНИЯ И ИСХОДОВ БЕРЕМЕННОСТИ У ПАЦИЕНТОК С ПОЗДНИМИ СТАДИЯМИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК] Article Demyanova K.A., Kozlovskaya N.L., Korotchaeva Y.V., Apresyan S.V., Rylceva L.P., Usatenko G.V., Lugovoj A.O., Vorobyeva M.A., Bondarenko T.V., Bespalova A.V., Volkova O.A. Terapevticheskii Arkhiv. Vol. 93. 2021. P. 685-692
EFFECTS OF HIGH-DOSE STATIN THERAPY ON COGNITIVE FUNCTIONS AND QUALITY OF LIFE IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Kobalava Z.D., Villevalde S.V., Vorobyeva M.A. Kardiologiia. KlinMed Consulting. Vol. 57. 2017. P. 34-41
GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Vorobyeva M.A., Azova M.M., Gigani O.O., Garmash I.V., Villevalde S.V., Kobalava Z.D. Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 13. 2017. P. 525-531
ALIROCOUMAB: NEW PERSPECTIVES OF LIPID-LOWERING THERAPY Article Kobalava Zh.D., Villevalde S.V., Vorobyeva M.A. Terapevticheskii Arkhiv. Vol. 89. 2017. P. 114-121